Back to search

Article

MiR-200c Sensitizes Breast Cancer Cells to Carboplatin Treatment by Decreasing MDR1 Expression

2021-04-26

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Breast cancer (BC) is one of the most common cancers worldwide and is associated with a high rate of cancer mortality in women. Resistance to chemotherapy is considered a significant problem and a major challenge for the treatment of patients with BC. miR-200c belongs to a family of miRNAs that act as tumor inhibitors. The expression level of miR-200c has been r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
58105437-5d88-5c2e-be0f-9944ecee1101
DOI
10.21203/rs.3.rs-440566/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MiR-200c Sensitizes Breast Cancer Cells to Carboplatin Treatment by Decreasing MDR1 ExpressionDOI 10.21203/rs.3.rs-440566/v1
Select a neighboring publication to make it the new centre.